Newport Exploration Ltd. (TSXV:NWX)

Verve Therapeutics Balance Sheet

Financials in millions CAD. Fiscal year is August - July.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 30, 2025	Jul 31, 2024	Jul 31, 2023	Jul 31, 2022	Jul 31, 2021	Jul 31, 2020
Cash & Equivalents	0.79	0.81	1.26	0.73	2.86	4.8
Short-Term Investments	1.69	0.86	1.42	2.6	2.42	2.02
Cash & Short-Term Investments	2.48	1.67	2.68	3.33	5.28	6.81
Cash Growth	34.80%	-37.50%	-19.71%	-36.94%	-22.43%	-1.86%
Other Receivables	0.75	0.93	1.17	2.59	2.81	1.82
Receivables	0.75	0.93	1.17	2.59	2.81	1.82
Prepaid Expenses	0.01	0.01	0.02	0.02	0.01	0.01
Total Current Assets	3.25	2.62	3.86	5.94	8.11	8.64
Property, Plant & Equipment	0.01	0.06	0.13	0.19	0.01	0.01
Total Assets	3.26	2.68	3.99	6.13	8.12	8.65
Accounts Payable	0	0.01	0.01	0.03	0.02	0.01
Accrued Expenses	0	0.02	0.02	0.03	0.03	0.03
Current Portion of Leases	0.01	0.06	0.06	0.06	-	-
Current Income Taxes Payable	-	-	-	0.41	0.48	0.17
Other Current Liabilities	0.02	0.02	0.02	0.02	0.02	0.01
Total Current Liabilities	0.03	0.1	0.11	0.54	0.53	0.21
Long-Term Leases	-	-	0.06	0.12	-	-
Total Liabilities	0.03	0.1	0.17	0.67	0.53	0.21
Common Stock	47.91	47.91	47.91	47.91	47.91	47.42
Retained Earnings	-47.17	-47.54	-46.3	-44.66	-42.54	-41.39
Comprehensive Income & Other	2.5	2.21	2.21	2.21	2.21	2.41
Shareholders' Equity	3.23	2.58	3.82	5.46	7.59	8.44
Total Liabilities & Equity	3.26	2.68	3.99	6.13	8.12	8.65
Total Debt	0.01	0.06	0.12	0.19	-	-
Net Cash (Debt)	2.47	1.61	2.55	3.15	5.28	6.81
Net Cash Growth	40.07%	-36.84%	-18.95%	-40.44%	-22.43%	-1.86%
Net Cash Per Share	0.02	0.02	0.02	0.03	0.05	0.07
Filing Date Shares Outstanding	105.58	105.58	105.58	105.58	105.58	104.43
Total Common Shares Outstanding	105.58	105.58	105.58	105.58	105.58	104.43
Working Capital	3.22	2.51	3.75	5.4	7.58	8.43
Book Value Per Share	0.03	0.02	0.04	0.05	0.07	0.08
Tangible Book Value	3.23	2.58	3.82	5.46	7.59	8.44
Tangible Book Value Per Share	0.03	0.02	0.04	0.05	0.07	0.08
Machinery	0	0.09	0.09	0.09	0.09	0.09

Source: S&P Global Market Intelligence. Standard template. Financial Sources.